Patents Assigned to A+ Science AB
  • Patent number: 6649589
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-&agr; comprising an effective amount of a TNF-&agr; inhibitor, as well as a method for treatment of such disorders, and the use of TNF-&agr; inhibitors in the preparation of pharmaceutical compositions for such treatment.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: November 18, 2003
    Assignee: A+ Science AB (publ)
    Inventors: Kjell Olmarker, Björn Rydevik
  • Patent number: 6635250
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of spinal disorders caused by the liberation of TNF-&agr; comprising an effective amount of a TNF-&agr; inhibitor, as well as a method for treatment of such disorders, and the use of TNF-&agr; inhibitors in the preparation of pharmaceutical compositions for such treatment.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: October 21, 2003
    Assignee: A+ Science AB (publ)
    Inventors: Kjell Olmarker, Björn Rydevik
  • Patent number: 6492337
    Abstract: The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, and specific catchers therefor (antibodies or lectins), in particular monoclonal antibodies, for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual and for use in the production of pharmaceutical preparations for treatment of said conditions is disclosed.
    Type: Grant
    Filed: September 21, 2000
    Date of Patent: December 10, 2002
    Assignee: A+ Science AB
    Inventors: Pam Fredman, Karsten Buschard